Search results
Major drug companies caught up in Cencora data loss
The Register· 29 minutes agoMore than a dozen big pharmaceutical suppliers have begun notifying individuals that their data was stolen when US drug wholesaler Cencora was breached...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 14 hours agoThis year, one of its more promising drug candidates, inaxaplin, has entered late-stage trials to study its effectiveness as a treatment for...
Drug companies pay doctors over A$11 million a year for travel and education - EconoTimes
EconoTimes· 3 days agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas...
Ozempic Patients Are Switching to These Less Expensive Weight-Loss Drugs — Best Life
Best Life· 3 days agoOzempic has taken the pharmaceutical world by storm in the last year. The semaglutide injection is...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 2 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Medicare is negotiating drug prices. Here's why that matters
Scripps News via AOL· 2 days agoFor the first time, Medicare is negotiating the prices of some prescription drugs. Here's why that...
Got $500? 3 Pharma Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 13 hours agoVertex Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) is worth buying today and holding forever because it has dominance in one...the market for...
GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — 2nd Update
Morningstar· 6 days agoGSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds ($3.81 billion) closer ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 hour ago(NASDAQ: VRCA) on behalf of long-term stockholders following a class action complaint that was filed against...from May 28, 2021 to May 24, 2022. In December 2020, Verrica submitted its New ...
Jump Financial LLC Takes $522,000 Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
ETF DAILY NEWS· 5 days agoJump Financial LLC purchased a new position in shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) during the 4th quarter, according to the company ...